Ticker: PCSA

Company: Processa Pharmaceuticals, Inc.

Person: Patrick Lin, officer

Transaction date: March 31, 2026

Reporting date: April 1, 2026

Average share price: 2.535

Bought 1603.0 shares for 4063.61